1. Home
  2. PRQR vs CIO Comparison

PRQR vs CIO Comparison

Compare PRQR & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • CIO
  • Stock Information
  • Founded
  • PRQR 2012
  • CIO 2013
  • Country
  • PRQR Netherlands
  • CIO Canada
  • Employees
  • PRQR N/A
  • CIO N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • CIO Real Estate Investment Trusts
  • Sector
  • PRQR Health Care
  • CIO Real Estate
  • Exchange
  • PRQR Nasdaq
  • CIO Nasdaq
  • Market Cap
  • PRQR 244.4M
  • CIO 221.6M
  • IPO Year
  • PRQR 2014
  • CIO 2014
  • Fundamental
  • Price
  • PRQR $2.17
  • CIO $6.95
  • Analyst Decision
  • PRQR Strong Buy
  • CIO Hold
  • Analyst Count
  • PRQR 8
  • CIO 1
  • Target Price
  • PRQR $8.88
  • CIO N/A
  • AVG Volume (30 Days)
  • PRQR 201.7K
  • CIO 1.1M
  • Earning Date
  • PRQR 08-07-2025
  • CIO 07-31-2025
  • Dividend Yield
  • PRQR N/A
  • CIO 5.75%
  • EPS Growth
  • PRQR N/A
  • CIO N/A
  • EPS
  • PRQR N/A
  • CIO N/A
  • Revenue
  • PRQR $20,129,184.00
  • CIO $168,892,000.00
  • Revenue This Year
  • PRQR N/A
  • CIO $1.13
  • Revenue Next Year
  • PRQR N/A
  • CIO $3.73
  • P/E Ratio
  • PRQR N/A
  • CIO N/A
  • Revenue Growth
  • PRQR 8.65
  • CIO N/A
  • 52 Week Low
  • PRQR $1.07
  • CIO $4.19
  • 52 Week High
  • PRQR $4.62
  • CIO $6.99
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 51.89
  • CIO 78.69
  • Support Level
  • PRQR $2.16
  • CIO $6.91
  • Resistance Level
  • PRQR $2.15
  • CIO $6.99
  • Average True Range (ATR)
  • PRQR 0.14
  • CIO 0.04
  • MACD
  • PRQR -0.03
  • CIO 0.02
  • Stochastic Oscillator
  • PRQR 42.11
  • CIO 97.79

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About CIO City Office REIT Inc.

City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.

Share on Social Networks: